Harrow (HROW) Current Deferred Revenue (2010 - 2026)
Harrow (HROW) recorded quarterly Current Deferred Revenue of $149000.0 in Q1 2026, down 81.09% quarter-over-quarter from $788000.0 in Q4 2025, and up 2.76% on a YoY basis from $145000.0 in Q1 2025.
Harrow (HROW) Current Deferred Revenue (2010 - 2026) Analysis & Trends
Harrow's Current Deferred Revenue history runs 13 years deep, the most recent figure standing at $149000.0 for Q1 2026.
- In Q1 2026, Current Deferred Revenue rose 2.76% year-over-year to $149000.0; the TTM figure through Mar 2026 stood at $149000.0 (up 2.76% YoY), while the FY2025 annual figure was $788000.0, up 1690.91% from the prior year.
- Current Deferred Revenue was $149000.0 for Q1 2026 at Harrow, down from $788000.0 in the prior quarter.
- In the past five years, Current Deferred Revenue ranged from a high of $788000.0 in Q4 2025 to a low of $23000.0 in Q1 2022.
- Historically, Current Deferred Revenue has averaged $165882.4 across 5 years, with a median of $115000.0 in 2022.
- The sharpest annual moves came in 2022 and 2025: Current Deferred Revenue soared 3733.33% in 2022, then sank 63.31% in 2025.
- A 5-year view of Current Deferred Revenue shows it stood at $113000.0 in 2022, then plunged by 33.63% to $75000.0 in 2023, then tumbled by 41.33% to $44000.0 in 2024, then soared by 1690.91% to $788000.0 in 2025, then slumped by 81.09% to $149000.0 in 2026.
- The last three Current Deferred Revenue figures came in at $149000.0 (Q1 2026), $788000.0 (Q4 2025), and $345000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Harrow | 1.25 Bn | 1.15 Bn | 27.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 149,000.00 |
| Dec 31, 2025 | 788,000.00 |
| Sep 30, 2025 | 345,000.00 |
| Jun 30, 2025 | 91,000.00 |
| Mar 31, 2025 | 145,000.00 |
| Dec 31, 2024 | 44,000.00 |
| Sep 30, 2024 | 137,000.00 |
| Jun 30, 2024 | 248,000.00 |
| Mar 31, 2024 | 112,000.00 |
| Dec 31, 2023 | 75,000.00 |
| Sep 30, 2023 | 153,000.00 |
| Jun 30, 2023 | 132,000.00 |
| Mar 31, 2023 | 67,000.00 |
| Dec 31, 2022 | 113,000.00 |
| Sep 30, 2022 | 115,000.00 |
| Jun 30, 2022 | 83,000.00 |
| Mar 31, 2022 | 23,000.00 |
| Dec 31, 2021 | 16,000.00 |
| Sep 30, 2021 | 3,000.00 |
| Jun 30, 2021 | 56,000.00 |